Scope of Services

Ultramikro, LLC is a consultant firm providing guidance for pharmaceutical and food industries in contamination control and in global pharmacopeial compliance. Particulate matter in the pharmaceutical presentation may be due to foreign material or due to substances intrinsic to the formulation, process or package. Detecting visible particles in the final product and tracking the subvisible particle load are key quality parameters and essential in product improvement activities. Reducing particle impact is quite dependent upon their identification, which is facilitated through analysis by a variety of instruments and approaches. Microscopical applications are foremost in the Ultramikro approach.

DS (Scott) Aldrich is owner and president of Ultramikro and has 40 years of industrial experience in pharmaceutical development and processing in commercial production and new product design and launch. He has extensive experience in active ingredient and excipient processing and in product forms such as oral liquid, oral solid dose (immediate and controlled release), emulsion, sterile injections, suspensions, lyophilized cake and topical presentations. Development and commercial product support include packaging selection (glass, metal, rubber, plastic) for conventional and device industries, package presentation and release inspection procedures.

DS Aldrich is a long-standing member of the Parenteral Drug Association, American Chemical Society and Microscopy Society of America. He has been an expert volunteer for the United States Pharmacopeia (USP) since 2005, and currently serves on the Dosage Forms expert committee for 2015-2020. The USP committee proposes and revises standards for pharmaceutical products, and focuses on many official chapters; including, <1> Injections, <381> Elastomeric Closures for Injections, <788> Particulate Matter in Injections and <789> Particulate Matter in Ophthalmic Solutions among others, and related monographs.

The firm provides, as primary services: